News

Filter

Current filters:

LicensingDermatologicals

1 to 9 of 48 results

Actavis to divest Doryx brand to Mayne Pharma for $50 million

Actavis to divest Doryx brand to Mayne Pharma for $50 million

10-02-2015

Ireland-headquartered generics major Actavis has entered an agreement with Mayne Pharma to divest the…

ActavisDermatologicalsDoryxFinancialGenericsLicensingMayne PharmaUSA

Ferrer licenses Canadian rights for ozenoxacin to Cipher Pharma

07-01-2015

Privately-held Spanish pharmaceutical company Ferrer says it has licensed commercialization rights for…

CanadaCipher PharmaceuticalsDermatologicalsFerrerLicensingOzenoxacinPharmaceutical

RXi and Hapten enter into licensing agreement for Samcyprone

RXi and Hapten enter into licensing agreement for Samcyprone

19-12-2014

RNA technology specialist RXi Pharmaceuticals Corp has entered into a global licensing agreement with…

BiotechnologyDermatologicalsLicensingNeurologicalRXi Pharmaceuticals

New Coronado Biosciences unit to acquire and license dermatology products for commercialization

New Coronado Biosciences unit to acquire and license dermatology products for commercialization

08-10-2014

US biopharma company Coronado Biosciences has formed a wholly-owned subsidiary, Journey Medical Corporation…

BiotechnologyCoronado BiosciencesDermatologicalsJourney Medical CorpLicensingManagementUSA

Merck & Co out-licenses tildrakizumab to Sun Pharma

Merck & Co out-licenses tildrakizumab to Sun Pharma

17-09-2014

US pharma giant Merck & Co has entered into an exclusive worldwide licensing agreement with Indian drugmaker…

DermatologicalsGlobalLicensingMerck & CoPharmaceuticalSun Pharmaceuticalstildrakizumab

Ranbaxy to distribute Cipher’s isotretinoin product in Brazil

25-07-2014

Canada’s Cipher Pharmaceuticals has signed a definitive distribution and supply agreement with India’s…

BrazilCipher PharmaceuticalsDermatologicalsIsotretinoinLicensingPharmaceuticalRanbaxy Laboratories

Sandoz in deal to commercialize Anacor’s Kerydin in USA

Sandoz in deal to commercialize Anacor’s Kerydin in USA

22-07-2014

USA-based Anacor Pharmaceuticals has entered into an exclusive agreement with Sandoz, a subsidiary of…

Anacor PharmaceuticalsBusiness FinanceDermatologicalsKerydinLicensingMajorNovartisOnychomycosisPharmaceuticalPharmaceutical industryPharmaDermSandozTopical solutionUSA

LEO Pharma strikes global dermatology deal with KLOK Tech

LEO Pharma strikes global dermatology deal with KLOK Tech

16-07-2014

Danish dermatology specialist LEO Pharma and Canada’s KLOX Technologies, both privately-held companies,…

Acne vulgarisDermatologicalsGlobalKLOX TechnologiesLEO PharmaLicensingPharmaceutical

1 to 9 of 48 results

Back to top